Free Trial
CVE:LXG

LexaGene (LXG) Stock Price, News & Analysis

LexaGene logo
C$0.10 -0.03 (-19.23%)
As of 02/21/2023

About LexaGene Stock (CVE:LXG)

Key Stats

Today's Range
C$0.10
C$0.14
50-Day Range
C$0.11
C$0.11
52-Week Range
C$0.07
C$0.31
Volume
2.14 million shs
Average Volume
170,061 shs
Market Capitalization
C$14.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

LXG Stock News Headlines

Pamapol Ord Share Price (0LXG)
Biosynex SA ALBIO
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Cyclopharm Ltd CYC
Lexagene Holdings Inc (LXGh)
Zhejiang Gongdong Medical Technology Co Ltd Class A
IIROC Trading Halt - LXG
See More Headlines

LXG Stock Analysis - Frequently Asked Questions

LexaGene's stock was trading at C$0.11 at the beginning of the year. Since then, LXG stock has increased by 0.0% and is now trading at C$0.11.

Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT), Inovio Pharmaceuticals (INO) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
CVE:LXG
CIK
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$8.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-339.54%
Return on Assets
-120.21%

Debt

Debt-to-Equity Ratio
138.01
Current Ratio
1.39
Quick Ratio
1.13

Sales & Book Value

Annual Sales
C$110.93 thousand
Price / Sales
133.13
Cash Flow
C$0.00 per share
Price / Cash Flow
21.25
Book Value
C$0.01 per share
Price / Book
10.50

Miscellaneous

Outstanding Shares
140,640,000
Free Float
N/A
Market Cap
C$14.77 million
Optionable
Not Optionable
Beta
2.26
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:LXG) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners